Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. - Wikidata - awgldk - TriplyDB

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

http://www.wikidata.org/entity/Q34651821

about

The mediator complex subunit 1 enhances transcription of genes needed for adrenal androgen production Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts 17β-Estradiol alters rat type-II alveolar cell recovery from high levels of ozone.Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells Estradiol increases mucus synthesis in bronchial epithelial cells.Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study Sex-specific modification of progesterone receptor expression by 17β-oestradiol in human cardiac tissues.Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.Sex-associated difference in estrogen receptor β expression in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancers in rats Targeting the intracellular MUC1 C-terminal domain inhibits proliferation and estrogen receptor transcriptional activity in lung adenocarcinoma cells.Smoking, passive smoking and lung cancer cell types among women in Morocco: analysis of epidemiological profiling of 101 cases.Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis.Estrogen metabolism within the lung and its modulation by tobacco smoke.Soy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis.Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells.Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma.Antiproliferative effect of exemestane in lung cancer cells.Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada.Structurally similar estradiol analogs uniquely alter the regulation of intracellular signaling pathways.Basal gene expression in male and female Sprague-Dawley rat nasal respiratory and olfactory epithelium.Effect of nonpersistent pesticides on estrogen receptor, androgen receptor, and aryl hydrocarbon receptor.MUC1/A and MUC1/B splice variants differentially regulate inflammatory cytokine expression Inhibition of non-small-cell lung cancer growth by combined fulvestrant and vandetanib.Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells.Risk of second breast cancer according to estrogen receptor status and family history.Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer.[Advances of targeted therapy based on estrogen receptor signaling pathway in lung cancer].Lung cancer mortality risk among breast cancer patients treated with anti-estrogens Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

P2860

Q24317277-D4B5446D-F3D6-471F-851F-F01CBC3CE5AE Q24706489-79C21E36-E56D-4BF4-B09C-57F50A288465 Q27687650-9709EB1B-69F0-4557-AE97-59577CC453C5 Q28397662-0C7BE3DE-7899-4EFB-AB96-C0C319FA3846 Q28568936-315EFF36-CE3B-47BB-8ED4-6F1869B18F5B Q31152613-132E57CD-0F7F-4AEC-AFC3-A76A43C65A90 Q33637261-46B4576F-95DA-43C5-AE5B-05556C2925B9 Q33695898-0C39900A-EE7A-4950-91A2-E3931FBD6B6F Q33806769-9DB286F8-8300-4FE1-9E28-4DEC27E6A147 Q33820667-FB5E4EA0-6BD2-467F-B24B-2FF53991A076 Q34119028-B09CAC72-1C93-4F37-A3BF-2E4AE7EF72FB Q34338071-9EBB756B-33BB-4394-9EEF-E0D6A4534324 Q34439850-009E53C3-B185-4F5B-95C7-79C417172B4A Q34526893-6041A688-5911-4B47-8013-F1CBD343C54A Q34719991-C01913F7-C988-4CAF-9648-A7AF4574ABDB Q35338975-30FA0B60-12F8-4A6E-868B-FD76E0ABECEA Q35343567-A1E18750-066A-4B8A-B00F-30B57DB1CD62 Q35541712-7657E57F-F898-4B18-812D-6AD821D359AA Q35798210-A3FCFF1B-8C78-4B0E-90B7-C47C5164FB22 Q36170332-303F9358-4ABF-41D6-8D6B-0A0924EB381E Q36487632-76608B8A-A05E-489F-A273-DC0ACE58682C Q36740713-54E65D8F-ECB4-4A40-8FF8-C49687BB051B Q36764972-EC5EC269-143C-4AD9-8891-412A662DC688 Q36775374-082B55E8-A37A-40E8-8908-7D3B3A1289C3 Q37399532-8022FC03-AFB5-4716-9D0C-5A22EEC8F1CB Q37440992-769A74B5-E67F-4247-8649-58B1894F668F Q37460552-C4DEAC58-F65D-42A7-8685-8F9F32E3DAA7 Q38110168-23351D33-B64A-42A1-A364-9A74BB82CD3F Q38320209-3FAE93AC-7DFC-4767-840A-BB7F0C719353 Q38515557-3632F3CD-8080-401C-BD9F-5B567FCEA80C Q39189309-A255B9A3-688A-4B91-B852-3672C68A8E46 Q39293642-7646E4FF-72E9-4C5E-B796-42A755665E5C Q39610522-86043818-73D3-4D72-86B3-292C9F386B05 Q42698173-13EC31B0-7D92-4727-A8D1-2F2F140E26F2 Q44558762-A2BAAAAA-CE56-4CD6-9094-563643AB007D Q51363166-04CC1663-F03A-42F9-AA87-499D90877051 Q55455337-993629B7-B805-4213-96E9-2B4534ED92B1 Q57665261-806651C7-5ABC-47B2-906B-EF7F843B8D11 Q58725269-ECE0865A-FADF-4866-AA3D-40DBDD68D33D

P2860

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

http://www.wikidata.org/entity/Q34651821

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Gender difference in the activ ...... man lung adenocarcinoma cells.

@ast

Gender difference in the activ ...... man lung adenocarcinoma cells.

@en

Gender difference in the activ ...... man lung adenocarcinoma cells.

@nl

type

label

Gender difference in the activ ...... man lung adenocarcinoma cells.

@ast

Gender difference in the activ ...... man lung adenocarcinoma cells.

@en

Gender difference in the activ ...... man lung adenocarcinoma cells.

@nl

prefLabel

Gender difference in the activ ...... man lung adenocarcinoma cells.

@ast

Gender difference in the activ ...... man lung adenocarcinoma cells.

@en

Gender difference in the activ ...... man lung adenocarcinoma cells.

@nl

P1433

Q34651821-D2534462-290A-43D1-A493-502EEC713BBF

P1476

Q34651821-29D930B6-89E1-4B6F-832C-213848241E7E

P2093

Q34651821-1102E484-DA3A-4564-929F-E254672488D4

Q34651821-19B0095A-6D65-4990-9C31-C66F90E7B2A0

Q34651821-23B99128-927A-4354-B95D-89F07E418072

Q34651821-258B51E8-E2AC-46CC-887C-03747C7CC62A

Q34651821-35DDAA90-8E0C-49D6-8B24-74A2119C56F6

Q34651821-4D8FBCBB-0A6E-4759-8607-09EB28AC87A3

Q34651821-59752CA7-62E4-4727-BAF3-BEDD80163123

Q34651821-BA152F50-9385-4B75-809C-71A7B4DF70F5

Q34651821-BE180EC4-63B6-4E88-AAFC-AB466DBB533C

P2860

Q34651821-03394A4D-A523-4099-B2F8-D2FB3040EF57

Q34651821-03BA9142-4B2E-4529-9FE0-6C6D4EBBB73C

Q34651821-06B0DC13-DF01-4EE3-909E-A8E033C16C15

Q34651821-071C6580-2B7C-44DC-899B-9F70E55152D7

Q34651821-0783C346-1125-45FC-B7F7-7E1FB2B9A6DE

Q34651821-0CE9DE60-8AB6-488E-9770-8D22630E85C9

Q34651821-0FB4CC9F-4E97-4F00-B555-59E21B33A70A

Q34651821-1A9AF818-2679-415D-82DD-E728D63461E4

Q34651821-1CDE5360-0C11-4503-B97C-A17BF4823275

Q34651821-240EB838-678A-440C-87B1-0ECCCE532FDE

P304

Q34651821-89621FD9-2E5B-4D6E-B872-6A2D08869B64

P31

Q34651821-4DD34550-5F87-4257-A495-01804898D57F

P356

Q34651821-59A5ADC7-9299-402B-8DB9-AA3E5D2A68C4

P433

Q34651821-D32D3B67-F8E7-4888-8178-359E4E040111

P478

Q34651821-901BADFB-0E4D-410A-BF44-CF88D4B43E9E

P577

Q34651821-354CCCBF-FB13-4912-9F02-3522FBA1AE84

P5875

Q34651821-2D4AEF4C-97E6-4ABE-A214-2110637167DA

P698

Q34651821-B965E2D0-6F56-4C45-8454-BABC58B967CA

P921

Q34651821-AFC953A7-3D7F-4618-BF04-44D90D54177A

P932

Q34651821-21CA4782-3E18-486B-AA25-44542552ACA1

P356

P1433

Endocrine-related cancer

P1476

Gender difference in the activ ...... man lung adenocarcinoma cells.

@en

P2093

Aimee R Bohn

http://www.w3.org/2001/XMLSchema#string

Carolyn M Klinge

http://www.w3.org/2001/XMLSchema#string

Kathleen A Mattingly

http://www.w3.org/2001/XMLSchema#string

Krista A Robinson

http://www.w3.org/2001/XMLSchema#string

Kristy A Blankenship

http://www.w3.org/2001/XMLSchema#string

Mary O Huff

http://www.w3.org/2001/XMLSchema#string

Susan M Dougherty

http://www.w3.org/2001/XMLSchema#string

William G McGregor

http://www.w3.org/2001/XMLSchema#string

Williard Mazhawidza

http://www.w3.org/2001/XMLSchema#string

P2860

The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro

MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription

Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer

Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.

Estrogen receptor interaction with co-activators and co-repressors

Coregulator function: a key to understanding tissue specificity of selective receptor modulators

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Response element sequence modulates estrogen receptor alpha and beta affinity and activity

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

P304

113-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1677/ERC.1.01118

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7179067

http://www.w3.org/2001/XMLSchema#string

P698

16601283

http://www.w3.org/2001/XMLSchema#string

P921

P932

1472635

http://www.w3.org/2001/XMLSchema#string